Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(10):794; doi:10.1093/jnci/92.10.794
© 2000 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 10, 794, May 17, 2000
© 2000 Oxford University Press

NEWS

Awards, Appointments, Announcements

The 23rd annual Bristol-Meyers Squibb Award for Distinguished Achievement in Cancer Research was awarded to David Beach, Ph.D., Hugh and Catherine Stevenson Chair of Cancer Biology at the Wolfson Institute, London; and Charles J. Sherr, M.D., Ph.D., chairman of the Department of Tumor Cell Biology at St. Jude Children’s Research Hospital, Memphis, Tenn.

Beach is known for his discovery of the role of cyclins in the cell division cycle. Sherr identified the mammalian G1 D-type cyclins as delayed-early response genes to growth factor stimulation. The two men received their shared $50,000 award at a ceremony in April in New York.

DuBois Receives Award

Raymond N. DuBois, M.D., Ph.D., received the Outstanding Investigator Award in Clinical Science from the American Federation for Medical Research at its annual meeting in April in San Diego.

DuBois is the Mina Cobb Wallace Professor of Gastroenterology and Cancer Prevention, director of gastroenterology and associate director for cancer prevention in the Vanderbilt-Ingram Cancer Center, Nashville, Tenn.

The Outstanding Investigator Award recognizes the important clinical implications of DuBois’ research in the role of the enzyme cyclooxygenase-2 in the development and progression of colon cancer.

Fisher Honored

Bernard Fisher, M.D., was awarded the American Surgical Association Medallion for Scientific Achievement. The medallion is the highest honor the Association bestows, and there have been only 14 prior recipients in the past 120 years.

Fisher is a founding member and former chairman of the National Surgical Adjuvant Breast and Bowel Project, Pittsburgh. Fisher’s investigations are responsible for the conduct of studies that have dramatically changed the way in which breast cancer is managed. Fisher is the scientific director of the NSABP and Distinguished Service Professor at the University of Pittsburgh.

Vanderbilt Names Matrisian

The Vanderbilt University School of Medicine named Lynn M. Matrisian, Ph.D., associate director for education in the Vanderbilt-Ingram Cancer Center, Nashville, Tenn., as the chairwoman of its new Department of Cancer Biology.

Matrisian is an internationally recognized researcher in the role of proteolytic enzymes in cancer. The cancer biology department, the first new basic science department at Vanderbilt in 45 years, will begin with six faculty members and is expected to grow to 20 members.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?